ICURE is a technology driven pharmaceutical company dedicated to the development and commercialization of novel proprietary drug delivery systems based transdermal formulations. Icure’s technology platforms cover topical, local and systemic delivery of biologically active ingredients by using transdermal plasters, patches, hydrogels and hydrocolloids.
The company has successfully developed and commercialized various patches and hydrogels for the treatment rheumatic arthritis pain, nicotine replacement therapy, medicated wound dressings, skin care, and dental care. These products have been licensed to several leading pharmaceutical firms for sales. The products pipeline is also aimed at the development of prescription drugs to diseases of central nervous system, asthma, and pain.
ICURE's mission is to find means and methods that would permit transdermal delivery of broad range of drugs in therapeutic doses and at a predictable rate, without affecting integrity of skin even after prolonged and repeated applications.
www.icure.co.kr
www.yufit.co.kr